Want to see IN:TTKHLTCARE full AI Analyst Report?

TTK Healthcare Limited (TTKHLTCARE) Price & Analysis

0 Followers

TTKHLTCARE Stock Chart & Stats

₹1082.70

-₹40.65(-3.73%)

At close: Jul 28 4:00 PM EDT

₹1082.70

-₹40.65(-3.73%)

Day’s Range― - ―

52-Week Range₹737.00 - ₹1,250.00

Previous CloseN/A

Volume18.95K

Average Volume (3M)2.64K

Market Cap

₹14.44B

Enterprise Value₹1.34B

Total Cash (Recent Filing)₹9.36B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)19.4

Beta0.88

Next Earnings

Oct 23, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.98%

Share Statistics

EPS (TTM)52.34

Shares Outstanding14,130,333

10 Day Avg. Volume920

30 Day Avg. Volume2,638

Financial Highlights & Ratios

PEG Ratio-0.86

Price to Book (P/B)0.99

Price to Sales (P/S)1.29

P/FCF Ratio-41.08

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetVery low leverage reduces solvency risk and interest burden, giving TTK Healthcare greater financial flexibility than a heavily indebted peer. A growing equity base and asset base can support product development, distribution investment, and resilience through operating volatility.

Multi-Year Revenue GrowthThe company has demonstrated an established ability to expand revenue while maintaining positive earnings and generally healthy net margins. This combination suggests its healthcare portfolio and distribution model retain customer relevance, supporting continued business durability over coming quarters.

Diversified Healthcare PortfolioExposure to both branded consumer healthcare and medical devices broadens the company’s revenue base across end markets and purchasing channels. Retail and institutional participation can diversify demand, while the TTK Group affiliation and own-product portfolio support commercial positioning.

Bears Say

Sustained Cash BurnPersistent negative operating and free cash flow indicate that reported earnings are not converting reliably into cash. Even with low debt, continued cash burn can reduce funding flexibility, constrain reinvestment, and make working-capital or investment demands more important to near-term financial resilience.

Recent Margin PressureA significant decline in gross profit and EBITDA margins can weaken earnings quality if it persists across the product mix or operating base. Lower margins reduce the cash generated from each rupee of sales and may limit the company’s ability to fund distribution, innovation, and brand investment.

Slowing Revenue GrowthThe deceleration from stronger earlier growth indicates that expansion is losing pace, even though the business remains profitable. Slower sales growth can make margin recovery and earnings improvement more dependent on pricing, mix, and execution rather than broad-based market expansion.

TTK Healthcare Limited News

TTK Healthcare Files SEBI Compliance Certificate for June Quarter

The latest announcement is out from TTK Healthcare Limited ( ($IN:TTKHLTCARE) ). TTK Healthcare Limited has submitted a...

3M ago

TTK Healthcare Shareholder Declares Nil Holding Under SEBI Takeover Rules

The latest announcement is out from TTK Healthcare Limited ( ($IN:TTKHLTCARE) ). TTK Healthcare Limited disclosed that shareholder...

6M ago

TTK Healthcare Seeks Shareholder Nod via E-Voting to Appoint New Independent Director

TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) has issued an announcement. TTK Healthcare Limited has launched a postal ballot...

10M ago

TTK Healthcare Board Appoints New Independent Director, Seeks Shareholder Nod via Postal Ballot

An update from TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) is now available. TTK Healthcare Limited’s board has approved...

10M ago

TTKHLTCARE FAQ

What was TTK Healthcare Limited’s price range in the past 12 months?

TTK Healthcare Limited lowest stock price was ₹737.00 and its highest was ₹1250.00 in the past 12 months.

What is TTK Healthcare Limited’s market cap?

TTK Healthcare Limited’s market cap is ₹14.44B.

When is TTK Healthcare Limited’s upcoming earnings report date?

TTK Healthcare Limited’s upcoming earnings report date is Oct 23, 2026 which is in 11 days.

How were TTK Healthcare Limited’s earnings last quarter?

TTK Healthcare Limited released its earnings results on Aug 06, 2026. The company reported ₹15.059 earnings per share for the quarter.

Is TTK Healthcare Limited overvalued?

According to Wall Street analysts TTK Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does TTK Healthcare Limited pay dividends?

TTK Healthcare Limited pays a Annually dividend of ₹10 which represents an annual dividend yield of 0.98%. See more information on TTK Healthcare Limited dividends here

What is TTK Healthcare Limited’s EPS estimate?

TTK Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TTK Healthcare Limited have?

TTK Healthcare Limited has 14,130,333 shares outstanding.

What happened to TTK Healthcare Limited’s price movement after its last earnings report?

TTK Healthcare Limited reported an EPS of ₹15.059 in its last earnings report. Following the earnings report the stock price went up 4.538%.

Which hedge fund is a major shareholder of TTK Healthcare Limited?

Currently, no hedge funds are holding shares in IN:TTKHLTCARE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

TTK Healthcare Limited

TTK Healthcare Limited is a diversified enterprise operating across multiple sectors in India and globally. Its extensive activities encompass animal welfare, offering veterinary therapeutic solutions and feed supplements. The human pharmaceuticals division provides a range of herbal and allopathic formulations. Within consumer products, the company is responsible for marketing and distributing items such as Woodward's Gripewater, the EVA cosmetics line, and Good Home scrubbers and air fresheners. Its medical devices segment manufactures and supplies artificial heart valves, in addition to developing orthopedic implants and surgical instruments. Furthermore, TTK Healthcare produces and markets protective devices, including male contraceptives. The food segment specializes in manufacturing and selling processed food items like potato and cereal-based pellets. Notably, the company also engages in map and atlas printing and publishing through its 'Others' segment. Founded in 1958 and headquartered in Chennai, India, TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.